DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Philip PA, Mahoney MR, Allmer C , et al.
Phase II study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer.
J Clin Oncol 2005;
23 (27) 6657-6663
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.